Daiichi Sankyo/AstraZeneca Get Two Lucky Breaks For Enhertu

 
• By Alaric DeArment
Daiichi/Sankyo got approval for Enhertu in NSCLC, while an arbitrator ruled in DS's favor • Source: Shutterstock

More from New Products

More from Scrip